L287-1326 Screening compound: 8-{[4-(5-cyclobutyl-1,2,4-oxadiazol-3-yl)thiophen-2-yl]sulfonyl}-1,4-dioxa-8-azaspiro[4.5]decane

L287-1326 Screening compound: 8-{[4-(5-cyclobutyl-1,2,4-oxadiazol-3-yl)thiophen-2-yl]sulfonyl}-1,4-dioxa-8-azaspiro[4.5]decane
L287-1326 Screening compound: 8-{[4-(5-cyclobutyl-1,2,4-oxadiazol-3-yl)thiophen-2-yl]sulfonyl}-1,4-dioxa-8-azaspiro[4.5]decane alternative view

Chemical Structure Depiction of ChemDiv screening compound L287-1326
8-{[4-(5-cyclobutyl-1,2,4-oxadiazol-3-yl)thiophen-2-yl]sulfonyl}-1,4-dioxa-8-azaspiro[4.5]decane

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L287-1326

Molecular Formula

C17H21N3O5S2 (C17 H21 N3 O5 S2)

Compound Name

8-{[4-(5-cyclobutyl-1,2,4-oxadiazol-3-yl)thiophen-2-yl]sulfonyl}-1,4-dioxa-8-azaspiro[4.5]decane

IUPAC name

8-{[4-(5-cyclobutyl-124-oxadiazol-3-yl)thiophen-2-yl]sulfonyl}-14-dioxa-8-azaspiro[4.5]decane

SMILES

O=S(c1cc(-c2noc(C3CCC3)n2)cs1)(N(CC1)CCC11OCCO1)=O

InChI

InChI=1S/C17H21N3O5S2/c21-27(22,20-6-4-17(5-7-20)23-8-9-24-17)14-10-13(11-26-14)15-18-16(25-19-15)12-2-1-3-12/h10-12H,1-9H2

InChI Key

UADJMUIDVCFGNN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27240841

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

411.5

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.712

Distribution Coefficient, logD

2.712

Water Solubility, LogSw

-3.00

Polar Surface Area

79.334

Acid Dissociation Constant (pKa)

26.82

Base Dissociation Constant (pKb)

-2.38

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

64.70

L287-1326 in Drug Discovery

Included in Screening Libraries

Eccentric PPI Library (11937 compounds)

Protein-Protein Interaction Library (218420 compounds)

Targeted Diversity Library (40567 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with L287-1326 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L287-1326?
Check Price and Availability of L287-1326, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L287-1326 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L287-1326
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L287-1326
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L287-1326 available by request